Skip to main navigation

- Silverback - Corp Menu

  • About
    • Team
    • Management Team
    • Board of Directors
  • Science & Technology
    • ImmunoTAC® Platform
    • Tumor-Localized Myeloid Cell Activation
    • Publications
  • Pipeline
    • SBT6050
    • SBT6290
    • SBT8230
    • Additional Oncology Programs
    • Fibrosis Program
  • Careers
    • Open Positions
  • Contact
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • IR Resources
    Careers
    Silverback Logo
    Silverback Logo

    News Releases

    - Silverback - Investor Relations

    • Home
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • IR Resources
      • Email Alerts
      • Contact IR
    Silverback Therapeutics to Participate in the H.C. Wainwright Bioconnect Conference
    01-05-2022

    - Silverback - Investor Tools

    • Print Page
    • RSS Feeds
    • Email Alerts

    - Silverback - Corp Menu

    • About
      • Team
      • Management Team
      • Board of Directors
    • Science & Technology
      • ImmunoTAC® Platform
      • Tumor-Localized Myeloid Cell Activation
      • Publications
    • Pipeline
      • SBT6050
      • SBT6290
      • SBT8230
      • Additional Oncology Programs
      • Fibrosis Program
    • Careers
      • Open Positions
    • Contact
    • Investors
      • Overview
      • News & Events
      • Stock Information
      • Corporate Governance
      • Financials & Filings
      • IR Resources
    © Copyright 2022 - Silverback Therapeutics®
    Scroll to top